| Sno | Abstract Title | Abstract Type | Edit | Delete |
|---|---|---|---|---|
| 1 | Role of Neuromelanin in Parkinson’s disease Iria Carballo-Carbajal HTML | PDF | Add Spaker+ |
Keynote | ||
| 2 | Inzomelid is a CNS penetrant anti-inflammatory drug that blocks NLRP3 inflammasome activation targeted to prevent Synuclein Pathology and Dopaminergic Degeneration in Parkinson’s disease Matthew A Cooper HTML | PDF | Add Spaker+ |
Keynote | ||
| 3 | Glucocerebrosidase Gene Therapy for Parkinson’s disease Jose Luis Lanciego Perez HTML | PDF | Add Spaker+ |
Keynote | ||
| 4 | A researcher’s perspective on Parkinson’s disease Rebecca Dyanne Wooten HTML | PDF | Add Spaker+ |
Keynote |